InsiderTrades

Form 4 for G Genpact LTD

Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001567619-23-003417 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-21 2023-02-16 G Stein Kathryn Vanpelt SVP S - Sale+OE $47.29 -55.5K 66.2K -46% -$2.62M
D 2023-02-21 2023-02-16 G Stein Kathryn Vanpelt SVP M - OptEx $27.70 +45.0K 121.7K +59% +$1.25M
D 2023-02-21 2023-02-16 G Stein Kathryn Vanpelt SVP M - OptEx $0.00 -45.0K 123.1K -27% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2023-02-16 S D 45,000 $47.29 76,706 D — — (F1) The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.00 to $47.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
2 Common Common Shares 2023-02-16 M A 45,000 $27.70 121,706 D — —
3 Common Common Shares 2023-02-16 S D 10,500 $47.30 66,206 D — — (F2) The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.02 to $47.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
4 Derivative Employee Stock Option (Right to Buy) 2023-02-16 M D 45,000 $0.00 123,101 D $27.70 · — to 2029-01-09 45,000 Common Shares (F3) The option vested 50% on January 10, 2022 and will vest 50% on January 10, 2024, subject to the reporting person's continued service through such date.